Financhill
Back

Celularity Stock Predictions

Celularity Stock Forecast

  • Is Celularity Stock Undervalued?
    The current Celularity [CELU] share price is $2.24. The Score for CELU is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • CELU is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Celularity Stock Go Up Next Year?

Data Unavailable

Celularity Stock Rating

Data Unavailable

Celularity Stock Price History

Is CELU stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CELU is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
celularity.com

52-Week Data

52-Week High:
7.97
52-Week Low:
1.30

Prediction Charts

Market Cap:
50.4M
Price in USD:
2.24
Volume:
98K
Beta:
0.66

Technical Analysis

SMA50:
2.34
SMA100:
2.59
SMA200:
3.09
52-Wk Change:
32.23%

Stock Predictions

  • Is Celularity stock public?
    Yes, Celularity is a publicly traded company.
  • What is the Celularity stock quote today?
    The Celularity stock price is 2.24 USD today.
  • How to buy Celularity stock online?
    You can buy Celularity shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-9 2.28 2.30 2.45 2.10
Dec-10 2.28 2.34 2.64 2.23
Dec-11 2.30 2.32 2.55 2.24
Dec-12 2.32 2.30 2.43 2.17
Dec-13 2.26 2.22 2.38 2.22
Dec-16 2.22 2.31 2.43 2.22
Dec-17 2.25 2.20 2.34 2.20
Dec-18 2.18 2.26 2.30 2.17
Dec-19 2.27 2.23 2.30 2.16
Dec-20 2.18 2.33 2.50 2.16
Dec-23 2.32 2.28 2.41 2.25
Dec-24 2.25 2.28 2.35 2.25
Dec-26 2.26 2.14 2.34 2.10
Dec-27 2.04 2.24 2.28 2.04

Celularity Earnings

Data Unavailable

Celularity Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

* Celularity stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.